Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mabtornib Protocol.Vascular, Metabolic and Hormonal Effects of Angiogenesis Inhibitors and Epidermal Growth Factor Receptor Inhibitors

NCT00657098 is registered in ClinicalTrials.gov with University Medical Center Groningen as lead sponsor.

NCT NCT00657098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00657098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mabtornib Protocol.Vascular, Metabolic and Hormonal Effects of Angiogenesis Inhibitors and Epidermal Growth Factor Receptor Inhibitors
Lead sponsor
University Medical Center Groningen
Phase
Observational
Overall status
Terminated
Start date
March 31, 2008
Completion date
October 31, 2015
Enrollment
73 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic malignancies